Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT05340569
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of pancreatic ductal adenocarcinoma.
* Resectable disease or borderline resectable disease based on CT.
* Tumor size ≥ 3 cm.
* CA 19-9 ≥ 400 U/mL with normal bilirubin level (\< 40)
* No evidence of distant metastases.
* Patient fit for pancreatic resection (ECOG 0 or 1).
Exclusion Criteria:
* Impossibility to obtain tissue diagnosis preoperatively confirming pancreatic ductal adenocarcinoma.
* Locally advanced disease on CT.
* Tumor size \< 3 cm.
* CA 19-9 \< 400 U/mL or CA 19-9 ≥ 400 U/mL with no preoperative drainage.
* Suspicion of distant metastases, including peritoneal metastases, on CT.
* Patient who is unable to have MRI.
* Patient unfit for pancreatic resection (ECOG 2 or more).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05340569
Study Brief:
Protocol Section:
NCT05340569